539. GS-CA2: A Novel, Potent, and Selective First-In-class Inhibitor of HIV-1 Capsid Function Displays Nonclinical Pharmacokinetics Supporting Long-Acting Potential in Humans

Jim Zheng, Winston C. Tse, Shekeba Ahmadyar et al.|Open Forum Infectious Diseases|2018

Cited by 15